Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
The present invention comprises novel preparations of polyoxypropylene/polyoxyethylene copolymers which retain the therapeutic activity of the commercial preparations, but are substantially free from the undesirable effects which are inherent in the prior art preparations. Because the preparations of polyoxypropylene/polyoxyethylene copolymers which comprise the present invention are a less polydisperse population of molecules than the prior art polyoxypropylene/polyoxyethylene copolymers, the biological activity of the copolymers is better defined and more predictable.
patent: Re29909 (1979-02-01), Kertz
patent: 2674619 (1954-04-01), Lundsted
patent: 2854378 (1958-09-01), Buckwalter et al.
patent: 3089818 (1963-05-01), Stone
patent: 3140232 (1964-07-01), Noseworthy
patent: 3391196 (1968-07-01), Earing et al.
patent: 3450502 (1969-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3590125 (1971-06-01), Hymes
patent: 3641240 (1972-02-01), Hymes et al.
patent: 3740421 (1973-06-01), Schmolka
patent: 3867521 (1975-02-01), Miskel et al.
patent: 3956259 (1976-05-01), Garcia et al.
patent: 3980772 (1976-09-01), Ginger et al.
patent: 4073886 (1978-02-01), Kehm
patent: 4100271 (1978-07-01), Krezanoski
patent: 4104455 (1978-08-01), Nagasawa et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4186253 (1980-01-01), Yokoyama et al.
patent: 4195167 (1980-03-01), Knopf et al.
patent: 4275244 (1981-06-01), Helfort et al.
patent: 4305922 (1981-12-01), Rhodes
patent: 4395393 (1983-07-01), Schmolka
patent: 4407790 (1983-10-01), Oakes et al.
patent: 4600652 (1986-07-01), Solomon et al.
patent: 4609546 (1986-09-01), Hiratani
patent: 4764567 (1988-08-01), Ou
patent: 4837014 (1989-06-01), Hunter et al.
patent: 4873083 (1989-10-01), Hunter et al.
patent: 4879109 (1989-11-01), Hunter
patent: 4897263 (1990-01-01), Hunter
patent: 4937070 (1990-06-01), Hunter
patent: 4997644 (1991-03-01), Hunter
patent: 5017370 (1991-05-01), Hunter et al.
patent: 5028599 (1991-07-01), Hunter
patent: 5030448 (1991-07-01), Hunter
patent: 5032394 (1991-07-01), Hunter
patent: 5039520 (1991-08-01), Hunter
patent: 5041288 (1991-08-01), Hunter
patent: 5047236 (1991-09-01), Hunter et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5064643 (1991-11-01), Hunter et al.
patent: 5071649 (1991-12-01), Hunter
patent: 5078995 (1992-01-01), Hunter et al.
patent: 5080894 (1992-01-01), Hunter et al.
patent: 5089260 (1992-02-01), Hunter et al.
patent: 5114708 (1992-05-01), Hunter et al.
patent: 5183687 (1993-02-01), Hunter et al.
patent: 5294365 (1994-03-01), Welch et al.
patent: 5340916 (1994-08-01), Henn et al.
Robert Hunter et. al., The Adjuvant Activity of Nonionic Block Polymer Surfactants: I. The Role of Hydrophile-Lipophile Balance, The Journal of Immunology, vol. 127, No. 3, 1244-50 (Sep. 1981).
Irving R. Schmolka, Artificial Skin: I. Preparation and Properties of Pluronic F-127 Gels for Treatment of Burns, J. Biomed. Mater. Res., vol. 6, 571-82 (1972).
Thomas A. Lane and G. E. Lamkin, Increased Infection Mortality and Decreased Neutrophil Migration Due to a Component of an Artificial Blood Substitute, Blood, vol. 68, No. 2, 351-54 (Aug. 1986).
George T. Rodeheaver et. al., Mechanical Cleansing of Contaminated Wounds with a Surfactant, The American Journal of Surgery, vol. 129, 241-45 (Mar. 1975).
Alfred J. Crowle, Studies of Antitubercolosis Chemotherapy With an In Vitro Model of Human Tuberculosis, Seminars in Respiratory Infections, vol. 1, No. 4, 262-64 (Dec. 1986).
James H. Williams, Jr. et al., Modulation of Rat Granulocyte Traffic by a Surface Active Agent in Vitro and Bleomycin Injury, Proceedings of the Society for Experimental Biology and Medicine, vol. 188, 461-70 (1988).
Mervyn B. Forman et. al., Beneficial Long-Term Effect of Intracoronary Perfluorochemical on Infarct Size and Ventricular Function in a Canine Reperfusion Model, J. Am. Coll. Cardiol, vol. 9, No. 5 1082-90 (1987).
H. Ohyanagi et. al., Clinical Studies of Perfluorochemical Whole Blood Substitutes: Safety of Fluosol-DA (20%) in Normal Human Volunteers, Clinical Therapeutics, vol. 2, No. 4, 306-12 (1979).
F. H. Armstrong and K. C. Lowe, Effects of Emlsified Perfluorochemicals on Liver Cytochromes P-450 in Rats. Comp. Biochem. Physiol., vol. 94C, No. 1, 345-49 (1989).
National Institute of Health, Final Report: Supercritical Fluid Fractionation of Pluronic 68, (May 12, 1986).
P. K. Bentley et. al., Purification of Pluronic F-68 for Perfluorochemical Emulsification, J. Pharm. Pharmacol. 41, 661-63 (1989).
Herbert G. Nadeau and Paul H. Waszeciak, Separational Methods, Nonionic Surfactants, 893-920 (1967).
Alan C. Hymes et. al., Influence of an Industrial Surfactant (Pluronic F-68) on Human Amniotic Fluid Embolism, Amer. J. Ostet. Gynec., 1217-22 (Aug. 15, 1970).
Robert L. Hunter et. al., Nonionic Block Copolymer Surfactants as Immunological Adjuvants: Mechanisms of Action and Novel Formulations, Immunological Adjuvants and Vaccines, 133-144 (Plenum Publishing Corporation, 1989).
J. W. Cornforth et. al., Antituberculous Effect of Certain Surface-Active Polyoxyethylene Ethers in Mice, Nature, vol. 168, 150-53 (Jul. 28, 1951).
Noelene E. Byars and Anthony C. Allison, Adjuvant Formulation for Use in Vaccines to Elicit Both Cell-Mediated and Humoral Immunity, Vaccine, vol. 5, 223-28 (Sep. 1987).
Abstract: Database WPI Derwent Publications Ltd., London, GB; AN 82-14781E(08) regarding JP A 57 008 233 (Mitsui Petrochemical), Jan. 16, 1982.
Schmolka, I., "A Review Of Block Polymer Surfactants", Journal of the American Oil Chemists Society, 54, No. 3, pp. 110-116 (1977).
Block and Graft Copolymerization, vol. 2, (ed. by R. J. Ceresa, John Wiley & Sons, 1976) "The Applications of Block Copolymer Polyol Surfactants", L. G. Lundsted and I. R. Schmolka: pp. 174 through 205 and pp. 255-272 (references).
Reindorf, C.A., et al., "Perfluorocarbon Compounds: Effects on the Rheological Properties of Sickle Erythrocytes in vitro", American Journal of Hematology, vol. 19, pp. 229-236 (1985).
Padilla, F., et al., "Effect of Fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: in vitro studies" Federation Proceedings, vol. 34, pp. 1510-1512 (1975).
Vercellotti, G.M, et al., "Activation of Plasma Complement by Perfluorocarbon Artificial Blood: Probable Mechanism of Adverse Pulmonary Reactions in Treated Patients and Rationale for Corticosteroid Prophylaxis", Blood, vol. 59, pp. 1299-1304 (1982).
Rodeheaver, G.T., "Pluronic.RTM. F-68: A Promising New Skin Wound Cleanser", Ann Emerg Med, 9:11, pp. 572-576 (1980).
Janoff, A.S., et al., "The Modification of Human Erythrocyte Membrane Structure by Stabilizers: An Electron Spin Resonance Study", American Journal of Hematology, vol. 10, pp. 171-179 (1981).
Moore, A.R., et al., "Reduction Of Splenic Vascular Resistance During Profusion By Pluronic.RTM. P-68", Journal of Surgical Research, vol. 8, pp. 563-566 (1968).
Benner, K.U., et al., "Cold-Induced Platelet Aggregation In Vivo And Its Inhibition By A Nonionic Surface Active Substance", Thrombosis Research, vol. 2, pp. 331-342 (1973).
Hymes, A.C., et al., "The Influence Of An Industrial Surfactant Pluronic.RTM. F-68, In The Treatment of Hemorrhagic Shock", Journal of Surgical Research, vol. 11, pp. 191-197 (1971).
Hoie, J., et al., "Effects of Pluronic.RTM. F68, Poloralkol, On Vascular Resistance In Vivo", Journal of Surgical Research, vol. 11, pp. 515-517, (1971).
Grover, F.L., et al., "A Nonionic Surfactant And Blood Viscosity", Arch. Surg., vol. 106, pp. 307-310 (1973).
Grover, F.L., et al., "The Effect of Pluronic.RTM. F-68 On Circulatory Dynamics And Renal And Carotoid Artery Flow During Hemorrhagic Shock", Journal of Surgical Research, vol. 17, pp. 30-35 (1974).
Ketchum, L.D., et al., "Experimental Use Of Pluronic.RTM. F-68 In Microvascular Surgery", Plastic and Reconstructive Surgery, vol. 53, pp. 288-292 (1974).
Ketchum, L.D., "Pharmacological alterations in the clotting mechanism: Use in microvascular surgery", Journal of Hand Surgery, vol. 3, pp. 407-415 (1978).
Vasko, K. A., et al., "Poloxalkol.RTM. (Pluronic F-68): A pri
Culbreth Paula H.
Emanuele R. Martin
Hunter Robert L.
(Andy) Arismendi, Jr. A. M.
Solola Taofiq A.
Polyoxypropylene/polyoxyethylene copolymers with improved biolog does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with Polyoxypropylene/polyoxyethylene copolymers with improved biolog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyoxypropylene/polyoxyethylene copolymers with improved biolog will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2327087